Cartalax
Also known as: AED Tripeptide
Cartalax is a Khavinson bioregulator peptide (tripeptide: Ala-Glu-Asp) that targets cartilage and connective tissue. It supports collagen synthesis, improves joint health, and enhances tissue elasticity.
Research Status
Khavinson bioregulator - Russian research
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Mild redness, swelling, or itching at the injection site may occur within hours and typically resolves within 24-48 hours. Ensure proper site rotation and sterile technique to minimise risk.
Localised urticaria or mild rash may occur in individuals with sensitivity to peptides. Discontinue use and consult a healthcare provider if symptoms develop.
Occasional mild headache has been reported in early treatment cycles. Typically resolves with continued use or dose adjustment.
Mild nausea or stomach upset may occur with oral capsules, particularly on an empty stomach. Take with food as directed to minimise.
Repeated injections at the same site can cause localised fat loss or thickening. Prevent by rotating injection sites systematically with each dose and maintaining at least 1 inch between injection points.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 10-20 mg (capsule) or 1-3 mg (injectable) |
| Frequency | Daily for 10-20 days |
| Timing | With meals (oral) or flexible (injectable) |
| Route | Oral, Subcutaneous |
Used in 10-20 day cycles, repeat 2-4x/year. Oral or injectable.
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2–8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
| Sequence | Ala-Glu-Asp |
Cartalax is a tripeptide bioregulator (Ala-Glu-Asp) that acts as a tissue-specific regulator targeting cartilage and connective tissue metabolism. It stimulates collagen synthesis and fibroblast activity, enhancing extracellular matrix production and tissue repair. The peptide promotes joint elasticity and structural integrity by modulating growth factors and cellular signalling pathways involved in cartilage homeostasis.
Collagen Synthesis Upregulation
Cartalax stimulates fibroblasts to increase production of Type I and Type II collagen, the primary structural proteins in cartilage and connective tissue. This enhances tissue strength and elasticity.
Extracellular Matrix (ECM) Remodelling
The peptide promotes balanced ECM turnover by supporting proteoglycan synthesis and reducing excessive matrix degradation, maintaining cartilage integrity and joint function.
Tissue-Specific Gene Expression
As a Khavinson bioregulator, Cartalax acts as a regulatory peptide that modulates gene expression in target tissues (cartilage, tendons, ligaments) through receptor-mediated signalling, promoting tissue-specific repair and maintenance.
- Cartalax is a tripeptide derived from the Khavinson bioregulator family, designed to target cartilage and connective tissue specifically
- The peptide enhances collagen synthesis and fibroblast activity, supporting joint health and tissue elasticity
- Bioregulators work through tissue-specific signalling rather than systemic hormone replacement, making them selective for target tissues
- Clinical use in Russia and Eastern Europe has documented improvements in joint mobility and cartilage quality in osteoarthritis and sports injury contexts
Track your Cartalax research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Cartalax is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.